info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Peripheral Artery Disease Market Research Report Information By Treatment Type (Device, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Others), By Drugs (Lipid Lowering Drugs, Triple-H Therapy, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytic Agents, and Anti-Inflammatory Agents), By End User (Hospitals & Clinics, and Ambulatory Surgical Clinics) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/MED/1011-CR | 137 Pages | Author: Kinjoll Dey| February 2020

Global Peripheral Artery Disease Market Overview


Peripheral Artery Disease Market Size was valued at USD 2.69 Billion in 2023. The Peripheral Artery Disease market industry is projected to grow from USD 2.899 Billion in 2024 to USD 4.91 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.80% during the forecast period (2024 - 2032). Increased demands for minimally invasive procedures and growing elderly population are the key market drivers enhancing the market growth.


Peripheral Artery Disease Market


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


Peripheral Artery Disease Market Trends



  • Rise in demand for minimally invasive procedures is driving the market growth


Market CAGR for peripheral artery disease is being driven by the rising demand for minimally procedures. Growing demand for less invasive procedures and an uptick in peripheral arterial disease (PAD) cases are negatively impacting the market's expansion. Peripheral artery disease (PAD), which affects more than 200 million individuals worldwide and is linked to high mortality and morbidity, is described in the American Heart Association's 2021 report. The ageing of the world's population will probably lead to an increase in PAD cases in the future. Thus, as per the statistics, the number of PAD is growing more quickly, which ultimately is pushing the market for peripheral vascular devices.


Lower extremity peripheral artery disease (PAD) affects more than 230 million people worldwide and is associated with rising risk of a count of unfavorable clinical outcomes, including cardiovascular diseases like coronary heart disease and stroke and limb outcomes, as per a study published by American Heart Association in August 2021 and titled "Lower Extremity Peripheral Artery Disease Contemporary Epidemiology, Management Gaps, and Future Directions." Over the projected period, the market for peripheral vascular devices would benefit from the rising prevalence of PAD.


Other than COVID-19, which had a substantial impact on market, the COVID-19 pandemic had a detrimental impact on treatment and diagnostic methods. It also had a negative impact on research and development activities in the sector. The fact that many studies indicated that persons with heart illnesses were particularly vulnerable to COVID-19 also contributed to the decline in patient traffic to hospitals and diagnostic facilities.


For instance, the National Centre for Biotechnology Information reported that during the COVID-19 pandemic, cardiac procedural activity in England drastically decreased, with a deficit of about 45,000 procedures, with no increase in the risk of mortality for the majority of cardiac procedures performed during the pandemic. This finding has been supported by a research titled "Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality," which was published by the National Centre for Biotechnology Information in May 2021. This study demonstrates how COVID-19 has a detrimental effect on cardiology services. The investigation was also carried out in England. The investigation was also carried out in England. Thus, driving the Peripheral Artery Disease market revenue.


Peripheral Artery Disease Market Segment Insights


Peripheral Artery Disease Type Insights


The Peripheral Artery Disease market segmentation, based on type includes Device, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Others. The hemodynamic flow alteration devices segment dominated the market. Peripheral vascular illnesses, which are brought on by the growth of atherosclerotic plaques in the arteries that supply blood to numerous organs, the head, and the limbs, are treated with hemodynamic flow alteration devices.


Peripheral Artery Disease Drugs Insights


The Peripheral Artery Disease market segmentation is based on drugs, Lipid-Lowering Drugs, Triple-H Therapy, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytic Agents, and Anti-Inflammatory Agents. The triple-H therapy category generated the most income. After aneurysmal subarachnoid haemorrhage (SAH), cerebral vasospasm is frequently prevented and treated using induced hypertension, hypervolemia, and hemodilution (triple-H therapy). The effectiveness of triple-H therapy and its precise function in the management of the acute phase of SAH are still unknown, despite the fact that this paradigm has received universal support over the past 20 years.


Peripheral Artery Disease End User Insights


The Peripheral Artery Disease market segmentation is based on end user, includes Hospitals & Clinics, and Ambulatory surgical clinics. The hospitals & clinics category generated the most income. The segmental growth is anticipated to be boosted by rising healthcare capital equipment expenditures, the favorable influence of technology utilizing lifeline curves, and innovations in healthcare regulatory scenarios.


Figure 1 Peripheral Artery Disease Market, by End User, 2023 & 2032 (USD Billion)Peripheral Artery Disease Market, by End User, 2022 & 2032


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


Peripheral Artery Disease Regional Insights


By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American Peripheral Artery Disease market area will dominate this market, owing to an increase in the instances of cardiovascular diseases. In addition, the solid presence of industry players will boost market growth in this region.


Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Figure 2 PERIPHERAL ARTERY DISEASE MARKET SHARE BY REGION 2023 (USD Billion)PERIPHERAL ARTERY DISEASE MARKET SHARE BY REGION 2022


Source Secondary Research, Primary Research, MRFR Database and Analyst Review


Europe Peripheral Artery Disease market accounts for the second-largest market share due to the rising smoking, and obesity among the population within the region. Further, the German Peripheral Artery Disease market held the largest market share, and the UK Peripheral Artery Disease market was the fastest growing market in the European region


The Asia-Pacific Peripheral Artery Disease Market is expected to grow at the quickest CAGR from the period of 2023 to 2032. This is due to growing healthcare expenditures and growing geriatric population. Moreover, China’s Peripheral Artery Disease market held the largest market share, and the Indian Peripheral Artery Disease market was the fastest growing market in the Asia-Pacific region.


Peripheral Artery Disease Key Market Players & Competitive Insights


Leading market players are undergoing various innovations activity to diversify their product & service offerings, which will help the Peripheral Artery Disease market, grow even more. Market participants are undertaking various strategic tactics to grow their presence, with key market developments including new product innovations, contracts & agreements, mergers & acquisitions, higher investments, partnerships, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Peripheral Artery Disease industry must offer cost-effective items.


The producers are utilizing locally available raw materials to stand in the competition in the Peripheral Artery Disease industry to benefit clients and increase the market sector. In recent years, the Peripheral Artery Disease industry has offered some of the most significant advantages to medicine. Major players in the Peripheral Artery Disease market, including Philips N.V., Braun Melsungen AG, Medtronic, Bayer AG, Boston Scientific Corporation, Becton Dickinson and Company, Terumo Medical Corporation, Biotronik Cardinal Health., and others, are attempting to increase market demand by investing in research and development operations.


Becton Dickinson and Co. (BD) is a manufacturer and distributor of medical equipment, reagents, and instruments is. Syringes and pen needles, intravenous catheters, infusion pumps, disposables, automated medication dispensing and supply management systems, pre-fillable drug delivery systems, respiratory ventilation and diagnostic equipment and consumables, items for the secure collection and transportation of diagnostic specimens, instruments and reagent systems to detect a variety of infectious diseases and cancers, and clinical research tools are among its main products. Researchers who are working in the branch of life sciences, hospitals, clinics, the pharmaceutical sector, and the general public can all benefit from BD's products. In August 2022, The first-in-human trial of a peripheral sirolimus drug-coated balloon (DCB) has begun, according to BD (Becton, Dickinson and business) (NYSE BDX), a top  medical technology business.


Koninklijke Philips NV (Philips) is a diversified technology firm that creates and produces consumer electronics and medical solutions. Diagnostic imaging, enterprise diagnostic informatics, image-guided therapy, ultrasound, monitoring and analytics, sleep and respiratory care, population health management, linked care informatics, and therapeutic care are all sectors in which the business provides products and solutions. Products available include power toothbrushes, brush heads, baby bottles, sterilisers, breast pumps, shavers, groomers, trimmers, and items for skin, hair, and hair removal. It also sells personal care and dental healthcare items. In August 2020, A deal to acquire Intact Vascular, Inc., a company based in the United States that creates medical equipment for minimally invasive peripheral vascular operations, was announced by Royal Philips.


 Key Companies in the Peripheral Artery Disease market include



  • Philips N.V.,

  • Braun Melsungen AG,

  • Medtronic,

  • Bayer AG,

  • Boston Scientific Corporation,

  • Becton Dickinson and Company,

  • Terumo Medical Corporation,

  • Biotronik

  • Cardinal Health


Peripheral Artery Disease Industry Developments


June 2022 The FDA has approved the company's FreedomFlow Peripheral Guidewire, according to Cardio Flow, Inc., a maker of minimally invasive peripheral vascular devices for the treatment of peripheral arterial disease (PAD).


January 2022 The United States Food and Drug Administration (FDA) granted Cook Medical a breakthrough device designation for a brand-new drug-eluting stent for below the knee (BTK). This brand-new stent is designed to help those with persistent ischemia that poses a risk to their limbs.


Peripheral Artery Disease Market Segmentation


Peripheral Artery Disease Treatment Type Outlook



  • Device

  • Catheters

  • Plaque Modification Devices

  • Hemodynamic Flow Alteration Devices

  • Others


Peripheral Artery Disease Drugs Outlook



  • Lipid Lowering Drugs

  • Triple-H Therapy

  • Glucose Regulating Drugs

  • Blood Clot Preventing Drugs,

  • Inotropes,

  • Thrombolytic Agents,

  • Anti-Inflammatory Agents


Peripheral Artery Disease End User Outlook



  • Hospitals & Clinics

  • Ambulatory Surgical Clinics


Peripheral Artery Disease Regional Outlook




  • North America

    • US

    • Canada




  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe




  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific




  • Rest of the World

    • Middle East

    • Africa

    • Latin America



Peripheral Artery Disease Report Scope
Report Attribute/Metric Details
Market Size 2023 USD 2.69 Billion
Market Size 2024 USD 2.899 Billion
Market Size 2032 USD 4.91 Billion
Compound Annual Growth Rate (CAGR) 6.80% (2024-2032)
Base Year 2023
Market Forecast Period 2023-2032
Historical Data 2018- 2022
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Treatment Type, Drugs, End User, and Region
Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled Philips N.V., Braun Melsungen AG, Medtronic, Bayer AG, Boston Scientific Corporation, Becton Dickinson and Company, Terumo Medical Corporation
Key Market Opportunities Growing obesity and elderly population
Key Market Dynamics Increase in healthcare expenditures and rising consumer spending over health and fitness


Frequently Asked Questions (FAQ) :

The Peripheral Artery Disease market size was valued at USD 2.69 Billion in 2023.

The market is projected to grow at a CAGR of 6.80% during the forecast period, 2024-2032.

North America had the largest share in the market

The key players in the market are Philips N.V., Braun Melsungen AG, Medtronic, Bayer AG, Boston Scientific Corporation, Becton Dickinson and Company, Terumo Medical Corporation.

The Catheters category dominated the market in 2022.

The hospitals & clinics had the largest share in the  market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.